In this regard, PET/CT and PET/MRI using radiolabeled prostate specific membrane antigen (PSMA)-targeted agents are considered very useful imaging methods in detecting PCa lesions both at staging and at restaging [5,6,7,8,9,10]. Here, FOLH1 is linked to posterior cortical atrophy.